Notes on the monographs

  • The rINN generic name is used where this has been agreed. When a choice of names is available the more commonly used in the UK has been provided. The list of trade names is not necessarily comprehensive, and the mention or exclusion of any particular commercial product is not a recommendation or otherwise as to its value. Any omission of a product that is authorized for a particular canine or feline indication is purely accidental. All monographs were updated in the period March–September 2022. Products that are not marketed for use in animals (whether authorized by the Veterinary Medicines Directorate (VMD) or not) are marked with an asterisk. Products that are authorized for use in dogs or cats are marked with a superscript or . Note that an indication that a product is authorized does not necessarily mean that it is authorized for all species and indications listed in the monograph; users should check individual data sheets. You may also wish to refer to the VMD’s Product Information Database.
  • Only medicines and formulations that are available in the UK have been included – many others are available outside the UK and some medicines in different formulations. Common trade names of human medicines are provided. In many cases they are available as generic formulations and may be cheaper. However, be careful of assuming that the bioavailability of one brand is the same as that of another. Avoid switching between brands unnecessarily.
  • and . Veterinary surgeons using this publication are warned that by the VMD or the European Medicines Agency (EMA) (either at all or for a particular species), or manufacturers’ recommendations may be limited to particular indications. Expert assistance should be obtained when necessary. The ‘cascade’ and its implications are discussed below. For information on combination drugs, it is important to refer to all relevant monographs.
  • This section only outlines specific risks and precautions for a particular drug that are in addition to the general advice given below in the ‘Health and safety in dispensing’ section. A separate Appendix deals with chemotherapeutic drugs.
  • and  The list of adverse reactions is not intended to be comprehensive and is limited to those effects that may be of clinical significance. The information for both of these sections is taken from published veterinary and human references and not just from product literature.
  • A listing of those interactions which may be of clinical significance.
  • These are based on those recommended by the manufacturers in their data sheets and package inserts or are based on those given in published articles or textbooks or are based on clinical experience. These recommendations should be used only as guidelines and should not be considered appropriate for every case. Clinical judgement must take precedence. Doses for small mammals, birds, reptiles and other groups of animals should never be extrapolated from the doses provided in this book for dogs and cats. The and other sources should be consulted where such doses are required. The colour banding on the antibiotic drug monographs denotes their category as classified by the EMA ().
  •  A listing of references and further reading to support the information in the monograph.
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error